SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-07-176142
Filing Date
2007-08-09
Accepted
2007-08-08 21:46:11
Documents
12
Period of Report
2007-06-30
Filing Date Changed
2007-08-08

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 771053
2 CERTIFICATE OF AMENDMENT OF THE RESTATED CERTIFICATE OF INCORPORATION dex32.htm EX-3.2 6471
3 CERTIFICATE OF CORRECTION OF THE RESTATED CERTIFICATE OF INCORPORATION dex33.htm EX-3.3 5088
4 AMENDMENT TO AMENDED AND RESTATED BYLAWS OF AMGEN INC dex35.htm EX-3.5 3375
5 AMGEN INC. DIRECTOR EQUITY INCENTIVE PROGRAM dex102.htm EX-10.2 31238
6 AMENDED AND RESTATED AMGEN INC. PERFORMANCE AWARD PROGRAM dex1029.htm EX-10.29 42206
7 FORM OF PERFORMANCE UNIT AGREEMENT TO THE AMENDED AND RESTATED AMGEN INC dex1030.htm EX-10.30 17317
8 AMENDMENT NO. 13 TO THE SHAREHOLDERS' AGREEMENT dex1045.htm EX-10.45 112559
9 PURCHASE AGREEMENT, DATED MAY 24, 2007 dex1076.htm EX-10.76 143562
10 PURCHASE AGREEMENT, DATED MAY 29, 2007 dex1077.htm EX-10.77 129037
11 SECTION 302 CEO AND CFO CERTIFICATION dex31.htm EX-31 20604
12 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32 9663
  Complete submission text file 0001193125-07-176142.txt   1293702
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 071037586
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1